242 related articles for article (PubMed ID: 33193301)
21. A Systems Biology Approach Identifies B Cell Maturation Antigen (BCMA) as a Biomarker Reflecting Oral Vaccine Induced IgA Antibody Responses in Humans.
Mottram L; Lundgren A; Svennerholm AM; Leach S
Front Immunol; 2021; 12():647873. PubMed ID: 33828557
[TBL] [Abstract][Full Text] [Related]
22. B cell activation through CD40 and IL4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRIL.
Ferrer G; Bosch R; Hodgson K; Tejero R; Roué G; Colomer D; Montserrat E; Moreno C
Br J Haematol; 2014 Feb; 164(4):570-8. PubMed ID: 24245956
[TBL] [Abstract][Full Text] [Related]
23. LT-IIc, a new member of the type II heat-labile enterotoxin family, exhibits potent immunomodulatory properties that are different from those induced by LT-IIa or LT-IIb.
Nawar HF; Greene CJ; Lee CH; Mandell LM; Hajishengallis G; Connell TD
Vaccine; 2011 Jan; 29(4):721-7. PubMed ID: 21095251
[TBL] [Abstract][Full Text] [Related]
24. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen.
Schneider P; Takatsuka H; Wilson A; Mackay F; Tardivel A; Lens S; Cachero TG; Finke D; Beermann F; Tschopp J
J Exp Med; 2001 Dec; 194(11):1691-7. PubMed ID: 11733583
[TBL] [Abstract][Full Text] [Related]
25. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
[TBL] [Abstract][Full Text] [Related]
26. Engineering an APRIL-specific B cell maturation antigen.
Patel DR; Wallweber HJ; Yin J; Shriver SK; Marsters SA; Gordon NC; Starovasnik MA; Kelley RF
J Biol Chem; 2004 Apr; 279(16):16727-35. PubMed ID: 14764606
[TBL] [Abstract][Full Text] [Related]
27. The role of the BAFF/APRIL system in the T cell-independent specific response to blood stage Plasmodium falciparum hemozoin.
Dechkajorn W; Benjathummarak S; Kumsiri R; Maneerat Y
Cytokine; 2018 Nov; 111():445-453. PubMed ID: 29884307
[TBL] [Abstract][Full Text] [Related]
28. CD4(+)CD25(+) T-cells control autoimmunity in the absence of B-cells.
Mariño E; Villanueva J; Walters S; Liuwantara D; Mackay F; Grey ST
Diabetes; 2009 Jul; 58(7):1568-77. PubMed ID: 19336675
[TBL] [Abstract][Full Text] [Related]
29. Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb.
Martin M; Metzger DJ; Michalek SM; Connell TD; Russell MW
Infect Immun; 2000 Jan; 68(1):281-7. PubMed ID: 10603399
[TBL] [Abstract][Full Text] [Related]
30. The role of APRIL and BAFF in lymphocyte activation.
Schneider P
Curr Opin Immunol; 2005 Jun; 17(3):282-9. PubMed ID: 15886118
[TBL] [Abstract][Full Text] [Related]
31. Expression of TNF-α, APRIL and BCMA in Behcet's disease.
Shaker OG; Tawfic SO; El-Tawdy AM; El-Komy MH; El Menyawi M; Heikal AA
J Immunol Res; 2014; 2014():380405. PubMed ID: 25759827
[TBL] [Abstract][Full Text] [Related]
32. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells.
Avery DT; Kalled SL; Ellyard JI; Ambrose C; Bixler SA; Thien M; Brink R; Mackay F; Hodgkin PD; Tangye SG
J Clin Invest; 2003 Jul; 112(2):286-97. PubMed ID: 12865416
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of humoral immunity by the type II heat-labile enterotoxin LT-IIb is dependent upon IL-6 and neutrophils.
Greene CJ; Hu JC; Vance DJ; Rong Y; Mandell L; King-Lyons N; Masso-Welch P; Mantis NJ; Connell TD
J Leukoc Biol; 2016 Aug; 100(2):361-9. PubMed ID: 27059843
[TBL] [Abstract][Full Text] [Related]
34. In vivo and in vitro adjuvant activities of the B subunit of Type IIb heat-labile enterotoxin (LT-IIb-B5) from Escherichia coli.
Liang S; Hosur KB; Nawar HF; Russell MW; Connell TD; Hajishengallis G
Vaccine; 2009 Jul; 27(32):4302-8. PubMed ID: 19450646
[TBL] [Abstract][Full Text] [Related]
35. Neutrophils contribute to excess serum BAFF levels and promote CD4+ T cell and B cell responses in lupus-prone mice.
Coquery CM; Wade NS; Loo WM; Kinchen JM; Cox KM; Jiang C; Tung KS; Erickson LD
PLoS One; 2014; 9(7):e102284. PubMed ID: 25010693
[TBL] [Abstract][Full Text] [Related]
36. B cell maturation antigen, the receptor for a proliferation-inducing ligand and B cell-activating factor of the TNF family, induces antigen presentation in B cells.
Yang M; Hase H; Legarda-Addison D; Varughese L; Seed B; Ting AT
J Immunol; 2005 Sep; 175(5):2814-24. PubMed ID: 16116167
[TBL] [Abstract][Full Text] [Related]
37. Novel function of TNF cytokines in regulating bone marrow B cell survival.
Zhang M; Ko KH; Lam QL; Lo CK; Xu DJ; Shen L; Zheng B; Srivastava G; Lu L
Cell Mol Immunol; 2004 Dec; 1(6):447-53. PubMed ID: 16293214
[TBL] [Abstract][Full Text] [Related]
38. Cellular membrane-based vesicles displaying a reconstructed B cell maturation antigen for multiple myeloma therapy by dual targeting APRIL and BAFF.
He C; Zhang M; Liu L; Han Y; Xu Z; Xiong Y; Yan F; Su D; Chen H; Zheng Y; Cheng F
Acta Biomater; 2022 Apr; 143():406-417. PubMed ID: 35218967
[TBL] [Abstract][Full Text] [Related]
39. Identification of proteoglycans as the APRIL-specific binding partners.
Ingold K; Zumsteg A; Tardivel A; Huard B; Steiner QG; Cachero TG; Qiang F; Gorelik L; Kalled SL; Acha-Orbea H; Rennert PD; Tschopp J; Schneider P
J Exp Med; 2005 May; 201(9):1375-83. PubMed ID: 15851487
[TBL] [Abstract][Full Text] [Related]
40. TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties.
Mackay F; Schneider P
Cytokine Growth Factor Rev; 2008; 19(3-4):263-76. PubMed ID: 18514565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
